Loading…
← CockpitCompetitor Analysis › 000503.SZ China Reform Health Management & Services Group Co., Ltd. Class AOpen in the cockpit ↗

China Reform Health Management & Services Group Co., Ltd. Class A000503.SZCompetitor analysis, valuation and peers

China · CNY·Information Technology›Information Technology Services
Momentum neutral 54
Mkt cap
$936M
US dollars, full cap
Free float
66%
of shares outstanding
$/day
$25.6M
20-day average traded
Fwd P/E
n/m
no positive forecast
ROIC−WACC
-17.6 pp
WACC 9.5%
Hurdle
n/a
no reverse DCF
Next earnings
159 days
26 Apr 2027
Close · CNYCN¥6.45
1D-0.1%
1W-10.7%
1M-18.9%
3M-13.2%
6M-16.2%
YTD-27.4%
1Y-36.3%
ATR %5.6%
52w lowhigh48.6% off high

What China Reform Health Management & Services does

Employees: 1,244

China Reform Health Management & Services at a glance

Size China Reform Health Management & Services (000503.SZ) is a China Information Technology company (Information Technology Services) with a market value of $936M, the 2283rd largest of 4,790 China companies the cockpit tracks. Shares closed at CN¥6.45 on 18 Nov 2026.

Performance Over six months the shares fell 16.2%, against -0.9% for the median peer and -20.0% for the China market (cap-weighted) — 10th lowest of 21 in its peer set.

Growth Revenue grew 6.1% over the last twelve months (peer median +6.5%); the operating margin is -45.3% (peer median 5.5%).

Valuation It trades at 18.2× enterprise value to sales against a peer median of 2.3× (4th most expensive of 21).

Capital Return on invested capital runs 17.6 points below its cost of capital (9.5% WACC).

Next results Next results expected around 26 Apr 2027 (exchange calendar; dates can move).

Relative performance

809010011021 May 202621 Aug 202618 Nov 2026Peer median 95000503.SZ 85
Six months, rebased to 100: China Reform Health Management & Services against the median of its 20 peers (local-currency closes).

China Reform Health Management & Services financials

Reported figures in CNY; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueCN¥346MCN¥349MCN¥354MCN¥329MCN¥309M
Revenue growth—-2%+8%+6%—
Gross profitCN¥102MCN¥69.2MCN¥49.2MCN¥74.7MCN¥47.7M
EBITDAn/a-CN¥111M-CN¥127M-CN¥84.9M-CN¥60.9M
Net income-CN¥408M-CN¥404M-CN¥10.4M-CN¥79.8M-CN¥84.3M
Free cash flow-CN¥112M-CN¥118M-CN¥120M-CN¥154M-CN¥192M
Capital expenditureCN¥40.8MCN¥45.7MCN¥37.6MCN¥52.1MCN¥37.7M
Total debtCN¥348MCN¥410MCN¥278MCN¥219MCN¥93.5M

Quarterly statements and history in the cockpit →

China Reform Health Management & Services competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-50%0%+50%+100%-20%0%+20%ASE300168002421446A6007974DX300226TANLA2317300598OSPNMAXGDYNRPD4417002380688258000503.SZ6-month return →1-month return →
Up and to the right = strong over both horizons. China Reform Health Management & Services is the large dot.

Fundamentals: revenue growth against valuation

-10%0%+10%+20%0×10×20×30×ASE300168002421446A6007974DX300226TANLA2317MAXRPD0023684417300300MITK688258000503.SZRevenue growth (TTM) →EV / Sales →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. China Reform Health Management & Services is the large dot.

China Reform Health Management & Services competitors and peer comparison

How China Reform Health Management & Services compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

China Reform Health Management & Services against its 20 peers (data as of 18 Nov 2026)
Measure000503.SZPeer medianRank in peer set
1-month return-18.9%-6.1%3rd lowest of 21
6-month return-16.2%-0.9%10th lowest of 21
Distance from 52-week high-48.6%-35.1%8th lowest of 21
Revenue growth (TTM)+6.1%+6.5%10th lowest of 21
Operating margin-45.3%5.5%3rd lowest of 21
EV / Sales18.2×2.3×4th most expensive of 21
ROIC minus cost of capital-17.6 pp+0.4 pp3rd lowest of 20

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginEV / SalesReq gDelivered g
China Reform Health Management & Services 000503.SZChina$936M-16%+6%-45%18.2×n/an/a
Asseco South Eastern Europe ASE.WAPoland$950M+17%+7%16%2.0×-0.1%+11.9%
Wonders Information 300168.SZChina$952M-21%+3%-17%4.1×49.4%-7.6%
Shenzhen Das Intellitech 002421.SZChina$904M-10%-17%-17%3.5×13.1%-8.8%
Northsand,Inc 446A.TJapan$969M+99%+60%21%4.2×-0.6%n/a
Insigma Technology 600797.SSChina$898M-31%-13%0%1.9×19.0%-2.9%
4DMedical 4DX.AXAustralia$893M-38%+21%-814%151.2×n/an/a
Shanghai Ganglian E-Commerce 300226.SZChina$889M-26%+1%0%0.1×4.9%+3.9%
Tanla Platforms TANLA.NSIndia$991M+33%+18%14%1.7×16.7%+13.5%
Systena 2317.TJapan$998M+8%+6%16%1.3×-11.1%+9.2%
ArcherMind Technology 300598.SZChina$847M-30%+7%-5%2.6×n/an/a
OneSpan OSPNUnited States$844M+78%+5%18%3.2×16.1%+2.4%
MediaAlpha MAXUnited States$838M+69%+15%7%0.7×-0.5%+13.7%
Grid Dynamics GDYNUnited States$1.05B+83%+7%4%1.8×28.1%+29.9%
Rapid7 RPDUnited States$1.05B+110%-1%3%1.5×16.3%+15.9%
Taiji Computer 002368.SZChina$1.05B-28%-37%-27%1.8×1.6%-1.8%
Global Security Experts 4417.TJapan$815M+202%+25%21%10.5×34.7%+30.2%
Strait Innovation Internet 300300.SZChina$797M-30%-8%-61%34.9×n/an/a
Nanjing Sciyon Wisdom Technology 002380.SZChina$792M-45%+7%12%1.9×6.8%+17.4%
Mitek Systems MITKUnited States$789M+18%+11%18%3.8×11.6%+12.1%
Jiangsu Eazytec 688258.SSChina$1.11B-53%0%28%22.0×34.3%+11.1%

Questions

Which companies are China Reform Health Management & Services's closest peers?
The cockpit's peer set: Asseco South Eastern Europe (ASE.WA), Wonders Information (300168.SZ), Shenzhen Das Intellitech (002421.SZ), Northsand,Inc (446A.T), Insigma Technology (600797.SS), 4DMedical (4DX.AX), Shanghai Ganglian E-Commerce (300226.SZ), Tanla Platforms (TANLA.NS).
Is China Reform Health Management & Services expensive compared with its peers?
On ev / sales it trades at 18.2× against a peer median of 2.3×, 4th most expensive of 21 in its peer set.
How has China Reform Health Management & Services stock performed?
Over six months to 18 Nov 2026 the shares returned -16.2% against -0.9% for the median peer; over one year -36.3%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.